Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences / biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
Using our distribution capabilities, we target a specific group of investors and organize meetings that can maximize management’s time. In our experience, an orchestrated process helps to streamline the transaction and thereby its competitiveness. A key to our success is aligning ourselves with top investors, strategic thinkers, entrepreneurs and executives around the world.
Latest Maxim Group News
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms,
Safe & Green Holdings Corp. (NASDAQ: SGBX) (“SG Holdings” or the “Company”), a leading developer,